Tumor microenvironment evaluation to predict pembrolizumab benefit of metastatic gastric cancer: Results from phase II clinical trial

Zeng, DQ; Liao, WJ; Shi, M; Zhou, R; Huang, N; Yu, YF; Peng, WY; Wu, JN; Ye, ZL

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

打开APP